Development of OR502, in antibody against leukocyte immunoglobulin-like receptor B2, to overcome suppression in the tumor microenvironment

Name: Development of OR502, in antibody against leukocyte immunoglobulin-like receptor B2, to overcome suppression in the tumor microenvironment
Start: 2027-04-13T11:40
End: 2027-04-13
Location: Boston Convention & Exhibition Center (BCEC)

Festival of Biologics USA · 13 April 2027 · 11:40

Development of OR502, in antibody against leukocyte immunoglobulin-like receptor B2, to overcome suppression in the tumor microenvironment was a session at Festival of Biologics USA on 13 April 2027 in Boston, with 1 speaker on record.

Speakers

Kamal Puri — Speaker CSO, OncoResponse